ARVO2020 cancelled because of Coronavirus (COVID-19)
ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA
News
New Technologies for Outcome Measures in Uveal Melanoma
Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology
Prof Andrew Dick reappointed as Director of IoO
Congratulations to Professor Andrew Dick for being reappointed as Director of UCL Institute of Ophthalmology for the next five years.
Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Treatment Roclanda
Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.
Beacon Bursaries awarded to IoO and Slade School of Fine Art joint project
IoO's Dr Emily Patterson and UCL Slade School of Fine Art's Jo Guile were selected in the latest round of the Beacon Bursary public engagement funding scheme.
International Council of Ophthalmology supports WHO’s guide on DR screening
The International Council of Ophthalmology participated in the launch of a diabetic retinopathy screening guide developed by the WHO Regional Office for Europe.
Tamara Fountain begins Term as 2021 President of the American Academy of Ophthalmology
The university professor will focus on pandemic recovery, supporting diversity in medicine
Fighting Blindness in the Developing World
From humble beginnings as a small clinic with just 11 beds and the audacious goal of curing preventable blindness, the Aravind Eye Care System in southern India has grown into the largest eye care provider in the world and serves as a model for how cataract blindness might effectively be eliminated in the developing world.
Le Professeur José-Alain Sahel au Téléthon 2020
José-Alain Sahel est intervenu lors du Téléthon 2020 pour évoquer les travaux de l’Institut sur les maladies rares de la Vision.
Drive-through IOP screening clinic feasible during COVID-19
A drive-through intraocular pressure (IOP) screening clinic allows for continued management during the COVID-19 pandemic, according to a research letter published in JAMA Ophthalmology.
Core curriculum: learning to manage a shared microscopy facility
High-tech tools are increasingly being consolidated into specialized centres. Running these technological wonderlands takes a unique blend of skills.
Global public health services fail to meet targets to reduce avoidable sight loss
A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.
The best science images of 2020
2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.
RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects
RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.
Glaucoma Research Foundation going global
In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.